Pharmaceutical

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

Kyowa Kirin has acquired Orchard Therapeutics, a developer of hematopoietic stem cell gene therapies, for an equity value of $477.6m.

Jan 25, 2024 - 18:00
Kyowa Kirin acquires Orchard Therapeutics for $477.6m
Kyowa Kirin has acquired Orchard Therapeutics, a developer of hematopoietic stem cell gene therapies, for an equity value of $477.6m.
Read the original article

Tags:

Previous Article

Evaxion Biotech to develop new vaccines for cancer

Next Article

Synnovation launches with $102m to advance therapy pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Allogene to pursue new strategy for development of off-the-shelf cell therapy in blood cancer

STAT+: Allogene to pursue new strategy for development ...

Jan 4, 2024

FDA greenlights Regeneron’s Dupixent for the treatment of COPD

FDA greenlights Regeneron’s Dupixent for the treatment ...

Sep 28, 2024

To protect chickens from bird flu, researchers try to CRISPR in immunity

To protect chickens from bird flu, researchers try to C...

Oct 10, 2023